IMM 20.3% 35.5¢ immutep limited

massive support , page-14

  1. 940 Posts.
    lightbulb Created with Sketch. 19
    As in any stock only positive news or rumour of positive news will move a stock forward? Day traders are another exception. Also ramping and down ramping.Regarding PRR we have not gone into a phase yet that is likely to increase the share price (Dramatically) until we have backing / support for the C/Vac and proven results from such trials.Which at this stage is unknown.Talk of DNDN is irrelevant to PRR as there is no gaurentee that their treatment is going to be the real deal???? Although very promising. I believe Prima will tick each box leading up to their next trial phase, but we all should also consider the facts that cancer research has for a long time not been able to deliver?
    I hope for all suffers of such debilitating diseases that Prima will deliver as will all other bio tech companies. Prima at least is on the front foot as is Dendreon.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.